< 1 minute read
Sep. 18, 2021

LEO 39652: A Novel “Dual-Soft” PDE4 Inhibitor

LEO 39652

"Dual-soft" topical PDE4 inhibitor soft drug to treat atopic dermatitis, lack of PD in Ph. I from metab. opt. of prev. discont. candidate J. Med. Chem., Oct. 15, 2020 LEO Pharma, Ballerup, DK

drughunter.com
Drug Hunter Team

LEO 39652 (LEO Pharma “dual-soft” topical PDE4 inhibitor soft drug clinical candidate)

Loading...

twitterlinkedinemail

Other molecules you may be interested in